Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

A new study published in the New England Journal of Medicine suggests that tirzepatide, a medication originally developed for ...

These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ... more complex than the weight loss injections listed above.

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

“At 1 year, you can see clearly there was a significant weight loss with both semaglutide and tirzepatide treatment ... with multiple daily insulin injections or an insulin pump.

Weight loss medications are often too expensive to afford out-of-pocket, typically marketed at an average price of $1000 per month. 2 Even with Eli Lilly’s recent self-pay alternative of a ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

Two recent tools in the battle for weight loss have been showing incredible results: Semaglutide and Tirzepatide ... is described as an anti-aging shot that wakes up human growth hormones lying ...